KalVista Pharmaceuticals (KALV) Times Interest Earned (2016)
Historic Times Interest Earned for KalVista Pharmaceuticals (KALV) over the last 3 years, with Q1 2016 value amounting to -$74.18.
- KalVista Pharmaceuticals' Times Interest Earned fell 116537.44% to -$74.18 in Q1 2016 from the same period last year, while for Jan 2017 it was -$270.34, marking a year-over-year change of. This contributed to the annual value of -$32.5 for FY2025, which is N/A changed from last year.
- Per KalVista Pharmaceuticals' latest filing, its Times Interest Earned stood at -$74.18 for Q1 2016, which was down 116537.44% from -$63.28 recorded in Q4 2015.
- Over the past 5 years, KalVista Pharmaceuticals' Times Interest Earned peaked at -$5.86 during Q1 2015, and registered a low of -$74.18 during Q1 2016.
- Its 3-year average for Times Interest Earned is -$36.37, with a median of -$31.44 in 2014.
- Per our database at Business Quant, KalVista Pharmaceuticals' Times Interest Earned skyrocketed by 7473.09% in 2015 and then tumbled by 116537.44% in 2016.
- Quarter analysis of 3 years shows KalVista Pharmaceuticals' Times Interest Earned stood at -$9.99 in 2014, then crashed by 533.2% to -$63.28 in 2015, then dropped by 17.22% to -$74.18 in 2016.
- Its Times Interest Earned stands at -$74.18 for Q1 2016, versus -$63.28 for Q4 2015 and -$51.57 for Q3 2015.